Exchange Traded Concepts, LLC Bei Gene, Ltd. Transaction History

Exchange Traded Concepts, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	BUY	$178.3 - $266.78 $90,398 - $135,257	507 New	507 $90,000
Q1 2021 Apr 20, 2021	SELL	$260.64 - $382.12 $588,264 - $862,444	-2,257 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$221.31 - $316.61 $63,294 - $90,550	-286 Reduced 11.25%	2,257 $583,000
Q3 2020 Oct 30, 2020	BUY	$189.18 - $286.44 $481,084 - $728,416	2,543 New	2,543 $728,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.3B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.